The fate is described of 11 patients who had a stored pulmonary valve homograft mounted on a frame or in a Dacron jacket used for mitral valve replacement. Mitral regurgitation due to holes in the attenuated cusps occurred in nine by one year, requiring re-operation or causing death. Only one patient remains well with moderate mitral regurgitation after two years.
Since January 1967, 118 patients have had mitral valve replacement with a preserved cadaver semilunar homograft valve mounted in a jacket or frame (Murray, Roschlau, and Lougheed, 1956; Heimbecker et al., 1962) . In all except 11 patients the aortic valve was used.
However, in the 11 patients in whom an inverted pulmonary valve was used (Lower, Stofer, and Shumway, 1961 ) the clinical course has been different. The purpose of this report is to draw attention to the problems and discourage the use of this form of mitral valve replacement.
MATERIAL
Between September 1968 and April 1969, 11 patients aged 24 to 66 years had mitral valve replacement with an inverted stored pulmonary valve homograft. The valves in five were sterilized by gamma-irradiation and in five by ethylene oxide. These valves were flash frozen and stored at -79°C. There is no record of the method of preparation in one.
In five patients the valve was mounted on a Dacron or Teflon covered strut of polypropylene (one RossKay, one lonescu, one Cutter) and in six it was wrapped in a Dacron or Teflon jacket (Yacoub and Kittle, 1969) .
All patients had severe and disabling symptoms at the time of operation and had had full medical treatment for a minimum of six months. Six had chronic congestive failure and three had had previous valve surgery. Five patients had homograft replacement of another valve at the same operation, and one 61-yearold had replacement of the ascending aorta for a dissecting aneurysm. There were no operative deaths. Clinical follow-up included regular documentation of the symptoms, physical signs, electrocardiogram, and chest radiograph. Recatheterization was undertaken on five after symptomatic deterioration. The gross appearance of the pulmonary valve was noted at death or re-operation, but histology was not available.
RESULTS
The follow-up of patients with a pulmonary valve in the mitral position varied from two weeks to lSupported by a grant from the Britiah Heart Foundation 2Requests for reprints to: Jane Somerville, Institute of Cardiology, 35 Wimpole Street, London WI M8EX two and a half years and the clinical findings are shown in the Table. Some of these patients lived for a longer period after replacement of the pulmonary homograft by a Starr or fascia lata valve. Six patients required re-operation for mitral regurgitation two weeks to 15 months after the initial replacement, and one of these died. In the patient operated on at two weeks, the graft had become detached from its jacket and folded inwards, causing mitral obstruction as well as regurgitation.
Of the remaining five patients, three died from heart failure three months, 14 months, and 15 months after operation, one is in severe heart failure 22 months later and has had re-operation, and the other (R.D.), who has signs of mitral regurgitation, is ambulant with a limited effort tolerance two and a half years after operation. Clean holes in the thin central part of one or more cusps were found in seven patients, and in four, two cusps were attenuated and thinned. In one (C.M.) the strut split, and in another (J.K.) a cusp had split away from the jacket and there was a separate hole in an attenuated cusp; in another (A.R.) there was central regurgitation but no holes. The valve was well incorporated but there was an exposed area of Dacron covered with platelet thrombus which might have been the source of embolism.
One patient had been unconscious from the time of operation with a tetraplegia; the mitral valve at three months had a hole in one thinned cusp 583 and a regurgitant murmur had appeared at one month. The pathology of the valve was not known in two patients as no necropsy was done in one and the other (R.D.) has not had re-operation.
A clear pansystolic murmur was documented two weeks to four months after operation in nine patients, and in six, reliable auscultators had not noted evidence of mitral regurgitation in the early postoperative weeks. Severe left heart failure usually occurred one to 12 months later, although in two, pulmonary oedema occurred quickly after the appearance of the murmur. Systemic emboli occurred in three patients one month, 18 months, and 22 months after operation and none was on anticoagulants at the time of embolism, although in one (A.R.) with the late embolus, anticoagulants had been given for the first postoperative month. The other eight patients had anticoagulants for a minimum of two months with no embolic problems.
DISCUSSION
The use of the pulmonary valve in the mitral position was tried because of its larger size in comparison with the aortic valve and also because of shortage of cadaver homografts. As can be seen from this experience, the results have been unsatisfactory; there was deterioration in six patients before six months had elapsed and a further three were in left heart failure by one year. Two patients remain well after 18 
